Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2007 June;32(2) > Minerva Endocrinologica 2007 June;32(2):87-94

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

REVIEWS  


Minerva Endocrinologica 2007 June;32(2):87-94

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane

Sheldahl L. C., Marriott L. K., Bryant D. N., Shapiro R. A., Dorsa D. M.

Department of Physiology and Pharmacology Oregon Health and Science University Portland, OR, USA


PDF  


Estrogen is neuroprotective in a large number of models in vivo and in vitro. Its application in hormone replacement therapy has proven to be more complicated, necessitating better understanding of how estrogen signals in the brain. Estrogen binds to estrogen receptors to regulate gene transcription, and activates a number of rapid signaling cascades from the plasma membrane. These rapid signaling cascades have been shown to play important roles in mediating the neuroprotective effects of estrogen. This review covers evidence that understanding and targeting the membrane effects of estrogen has emerged as an important area in the design of novel neuroprotective drugs.

top of page

Publication History

Cite this article as

Corresponding author e-mail